Treatment of gout by reduction of uric acid production.
D002374:Catalase / Q000627:therapeutic use; D004357:Drug Synergism; D057487:Enzyme Therapy; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D007669:Kidney Calculi / Q000517:prevention & control; D013442:Sulfinpyrazone / Q000627:therapeutic use; D014498:Uracil / Q000627:therapeutic use; D014527:Uric Acid / Q000096:biosynthesis*; D014528:Uricosuric Agents / Q000627:therapeutic use*; D014969:Xanthine Oxidase / Q000627:therapeutic use
D014528:Uricosuric Agents; D014527:Uric Acid; D014498:Uracil; D002374:Catalase; D014969:Xanthine Oxidase; D013442:Sulfinpyrazone